Ultragenyx Provides Financial and Business Updates at J.P. Morgan Annual Healthcare Conference
Ultragenyx Pharmaceutical Inc. Preliminary 2025 total revenue of $672 million to $674 million, exceeding top end of guidance Preliminary cash and...
Ultragenyx Pharmaceutical Inc. Preliminary 2025 total revenue of $672 million to $674 million, exceeding top end of guidance Preliminary cash and...
This year marks the flagship report's 30th anniversary, showcasing J.P. Morgan's long-standing market expertise and leading research capabilities NEW YORK,...
DISCLOSURES The information presented is not intended to be making value judgments on the preferred outcome of any government...
BERKELEY SPRINGS — Gov. Patrick Morrisey visited Berkeley Springs this week to announce a $75,000 grant aimed at boosting business...
NEW YORK, Oct. 21, 2024 /PRNewswire/ -- J.P. Morgan Asset Management today released its 2025 Long-Term Capital Market Assumptions (LTCMAs),...
DISCLOSURES The information presented is not intended to be making value judgments on the preferred outcome of any government...